WTX-124, a Conditionally Activated Wild-Type IL2, Maximizes the Therapeutic Index of IL2, Unlike "Non-Alpha" Muteins. - Nirschl CJ; Subramanian KK; Brodkin HR; Domonkos C; Dwyer CJ; Hicklin DJ; Isaacs R; Ismail NS; LePrevost J; Lewis Y; Morris K; Seidel-Dugan C; et al. (Cancer immunology research, 2026)